tranexamic acid has been researched along with Cystic Fibrosis in 7 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid was resumed with resolution of the hemoptysis, and the therapy has been used continuously for 13 months without any complications." | 5.31 | Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. ( Graff, GR, 2001) |
| "Hemoptysis was only partially controlled by repeated bronchial arterial embolizations." | 5.29 | Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid. ( Culham, G; Davidson, AG; DeJong, BP; Lillquist, YP; Wong, LT, 1996) |
| "Hemoptysis is a major cause of morbidity and mortality in patients with cystic fibrosis (CF)." | 1.51 | Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis. ( Al-Samkari, H; Cardoni, L; Connors, JM; McMahon, L; Perkins, R; Pighetti, EH; Rits, S; Shin, K; Uluer, A, 2019) |
| "Tranexamic acid was resumed with resolution of the hemoptysis, and the therapy has been used continuously for 13 months without any complications." | 1.31 | Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid. ( Graff, GR, 2001) |
| "Hemoptysis was only partially controlled by repeated bronchial arterial embolizations." | 1.29 | Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid. ( Culham, G; Davidson, AG; DeJong, BP; Lillquist, YP; Wong, LT, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Gavioli, E | 1 |
| Aung, CC | 1 |
| Al-Samkari, H | 1 |
| Shin, K | 1 |
| Cardoni, L | 1 |
| Pighetti, EH | 1 |
| Rits, S | 1 |
| McMahon, L | 1 |
| Perkins, R | 1 |
| Uluer, A | 1 |
| Connors, JM | 1 |
| Segrelles Calvo, G | 1 |
| De Granda-Orive, I | 1 |
| López Padilla, D | 1 |
| Hurley, M | 1 |
| Bhatt, J | 1 |
| Smyth, A | 1 |
| Wong, LT | 1 |
| Lillquist, YP | 1 |
| Culham, G | 1 |
| DeJong, BP | 1 |
| Davidson, AG | 1 |
| Chang, AB | 1 |
| Ditchfield, M | 1 |
| Robinson, PJ | 1 |
| Robertson, CF | 1 |
| Graff, GR | 1 |
7 other studies available for tranexamic acid and Cystic Fibrosis
| Article | Year |
|---|---|
Haemoptysis management in cystic fibrosis: A case report and treatment pathway.
Topics: Antifibrinolytic Agents; Cystic Fibrosis; Embolization, Therapeutic; Hemoptysis; Humans; Male; Middl | 2020 |
Antifibrinolytic Agents for Hemoptysis Management in Adults With Cystic Fibrosis.
Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Critical Pathways; Cystic Fibrosis; Drug Monitori | 2019 |
Inhaled Tranexamic Acid as an Alternative for Hemoptysis Treatment.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Antifibrinolytic Agents; Cystic Fibrosis; Hemop | 2016 |
Treatment massive haemoptysis in cystic fibrosis with tranexamic acid.
Topics: Adolescent; Cystic Fibrosis; Hemoptysis; Humans; Male; Tranexamic Acid | 2011 |
Treatment of recurrent hemoptysis in a child with cystic fibrosis by repeated bronchial artery embolizations and long-term tranexamic acid.
Topics: Antifibrinolytic Agents; Bronchial Arteries; Child; Cystic Fibrosis; Embolization, Therapeutic; Fema | 1996 |
Major hemoptysis in a child with cystic fibrosis from multiple aberrant bronchial arteries treated with tranexamic acid.
Topics: Adolescent; Antifibrinolytic Agents; Bronchial Arteries; Combined Modality Therapy; Cystic Fibrosis; | 1996 |
Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid.
Topics: Adult; Cystic Fibrosis; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hemoptysis; Hum | 2001 |